CH1055(Cat No.:I043811)is a selective inhibitor of the enzyme receptor tyrosine kinase, specifically targeting the vascular endothelial growth factor receptor 2 (VEGFR2). This receptor plays a pivotal role in angiogenesis, the process by which new blood vessels form from existing ones, a key event in tumor growth and metastasis. By inhibiting VEGFR2, CH1055 can reduce tumor vascularization, limiting tumor growth and spread. It shows promise as a therapeutic agent in cancer treatment, particularly in solid tumors, by targeting angiogenesis and enhancing the effectiveness of other anti-cancer therapies.